NovoCure Limited (NASDAQ:NVCR) Q4 2024 Earnings Call Transcript February 27, 2025
NovoCure Limited misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.34.
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that...
